IL17F Antibody

• Catalog Number: orb1272662
• Category: Antibodies
• Description: IL17F Antibody
• Species/Host: Rabbit
• Clonality: Polyclonal
• Tested applications: ELISA, NeA, WB
• Reactivity: Human
• Immunogen: Produced from sera of rabbits pre-immunized with highly pure (>98%) recombinant hIL-17F. Human IL-17F specific antibody was purified by affinity chromatography employing immobilized hIL-17F matrix.
• Concentration: batch dependent
• Dilution range: Neutralization: To yield one-half maximal inhibition [ND50] of the biological activity of hIL-17F (50.0 ng/mL), a concentration of 0.9-1.2 μg/mL of this antibody is required. ELISA:Indirect:To detect hIL-17F by indirect ELISA (using 100 μL/well antibody solution) a concentration of 0.5 - 2.0 μg/mL of this antibody is required. This antigen affinity purified antibody, in conjunction with compatible secondary reagents, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hIL-17F.SandwichTo detect hIL-17F by sandwich ELISA (using 100 μL/well antibody solution) a concentration of 0.5 - 2.0 μg/mL of this antibody is required. This antigen affinity purified antibody, in conjunction with our biotinylated Anti-Human IL-17F as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hIL-17F. Western Blot:To detect hIL-17F by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 μg/mL. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIL-17F is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.
• Form/Appearance: Lyophilized
• Conjugation: Unconjugated
• Target: IL17F
• UniProt ID: Q96PD4
• NCBI: Q96PD4
• Storage: The lyophilized antibody is stable for at least 2 years from date of receipt at -20°C. The reconstituted antibody is stable for at least two weeks at 2-80°C. Frozen aliquots are stable for at least 6 months when stored at -20°C. Avoid repeated freeze-thaw cycles.
• Alternative names: ML1, ML-1, CANDF6, IL-17FInterleukin-17F, Cytokine
• Note: For research use only
• Application notes: Neutralization: To yield one-half maximal inhibition [ND50] of the biological activity of hIL-17F (50.0 ng/mL), a concentration of 0.9-1.2 μg/mL of this antibody is required. ELISA:Indirect:To detect hIL-17F by indirect ELISA (using 100 μL/well antibody solution) a concentration of 0.5 - 2.0 μg/mL of this antibody is required. This antigen affinity purified antibody, in conjunction with compatible secondary reagents, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hIL-17F.SandwichTo detect hIL-17F by sandwich ELISA (using 100 μL/well antibody solution) a concentration of 0.5 - 2.0 μg/mL of this antibody is required. This antigen affinity purified antibody, in conjunction with our biotinylated Anti-Human IL-17F as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hIL-17F. Western Blot:To detect hIL-17F by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 μg/mL. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIL-17F is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.
• Expiration Date: 12 months from date of receipt.

To detect hIL-17F by sandwich ELISA (using 100 ul/well antibody solution) a concentration of 0.5 - 2.0 ug/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with Biotinylated Anti-Human IL-17F (orb1272674) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hIL-17F.

To detect hIL-17F by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 ug/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIL-17F is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.

To detect hIL-17F by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 ug/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIL-17F is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.